First Washington Corp Precigen, Inc. Transaction History

First Washington Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.08 - $1.85 $57,888 - $99,160	53,600 Added 9.04%	646,575 $918,000
Q4 2022 Feb 13, 2023	BUY	$1.27 - $2.26 $8,348 - $14,857	6,574 Added 1.12%	592,975 $901,000
Q2 2022 Aug 10, 2022	SELL	$1.15 - $2.53 $1,797 - $3,954	-1,563 Reduced 0.27%	586,401 $786,000
Q1 2022 May 11, 2022	BUY	$1.91 - $3.98 $28,000 - $58,346	14,660 Added 2.56%	587,964 $1.24 Million
Q4 2021 Feb 10, 2022	SELL	$3.53 - $5.5 $12,940 - $20,163	-3,666 Reduced 0.64%	573,304 $2.13 Million
Q1 2021 May 13, 2021	BUY	$6.74 - $10.95 $674,000 - $1.1 Million	100,000 Added 20.97%	576,970 $3.98 Million
Q4 2020 Feb 11, 2021	SELL	$3.75 - $10.56 $28,387 - $79,939	-7,570 Reduced 1.56%	476,970 $4.87 Million
Q2 2020 Aug 13, 2020	SELL	$2.16 - $5.46 $244,512 - $618,072	-113,200 Reduced 18.94%	484,540 $2.42 Million
Q1 2020 May 08, 2020	BUY	$1.46 - $7.19 $872,700 - $4.3 Million	597,740 New	597,740 $2.03 Million

140

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $281M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of First Washington Corp, based on Form 13F filings with the SEC.

Stay updated on First Washington Corp with notifications on news.